{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:10:47Z","timestamp":1792815047511,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG055909"],"award-info":[{"award-number":["R01AG055909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS117446"],"award-info":[{"award-number":["R01NS117446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG056011"],"award-info":[{"award-number":["R21AG056011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG10161"],"award-info":[{"award-number":["P30AG10161"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG72975"],"award-info":[{"award-number":["P30AG72975"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG15819"],"award-info":[{"award-number":["R01AG15819"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG17917"],"award-info":[{"award-number":["R01AG17917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG46152"],"award-info":[{"award-number":["U01AG46152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG61356"],"award-info":[{"award-number":["U01AG61356"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-21-720471"],"award-info":[{"award-number":["AARF-21-720471"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s Disease (AD) affects millions globally, but therapy development is lagging. New experimental systems that monitor neuronal functions in conditions approximating the AD brain may be beneficial for identifying new therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We expose cultured neurons to aqueous-soluble human brain extract from 43 individuals across a spectrum of AD pathology. Multi-electrode arrays (MEAs) and live-cell imaging were used to assess neuronal firing and neurite integrity (NI), respectively, following treatments of rat cortical neurons (MEA) and human iPSC-derived neurons (iN) with human brain extracts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We observe associations between spontaneous activity and A\u03b242:40 levels, between neurite integrity and oligomeric A\u03b2, and between neurite integrity and tau levels present in the brain extracts. However, these associations with A\u03b2 and tau do not fully account for the effects observed. Proteomic profiling of the brain extracts revealed additional candidates correlated with neuronal structure and activity. Neurotoxicity in MEA and NI assays was associated with proteins implicated in lysosomal storage disorders, while neuroprotection was associated with proteins of the WAVE regulatory complex controlling actin cytoskeleton dynamics. Elevated ganglioside GM2 activator (GM2A) associates with reductions in both NI and MEA activity, and cell-derived GM2A alone is sufficient to induce a loss of neurite integrity and a reduction in neuronal firing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The techniques and data herein introduce a system for modeling neuronal vulnerability in response to factors in the human brain and provide insights into proteins potentially contributing to AD pathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13024-022-00558-4","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T12:04:04Z","timestamp":1663761844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity"],"prefix":"10.1186","volume":"17","author":[{"given":"Yi-Chen","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Richard V.","family":"Pearse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc M.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori B.","family":"Chibnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7846-1542","authenticated-orcid":false,"given":"Tracy L.","family":"Young-Pearse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"issue":"4","key":"558_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6(4):37.","journal-title":"Alzheimers Res Ther"},{"issue":"5580","key":"558_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science."},{"issue":"9","key":"558_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"558_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"5","key":"558_CR5","doi-asserted-by":"publisher","first-page":"a005777","DOI":"10.1101\/cshperspect.a005777","volume":"4","author":"M Sheng","year":"2012","unstructured":"Sheng M, Sabatini BL, S\u00fcdhof TC. Synapses and Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol. 2012;4(5):a005777.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"558_CR6","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/s41467-018-05068-w","volume":"9","author":"M Jin","year":"2018","unstructured":"Jin M, O\u2019Nuallain B, Hong W, Boyd J, Lagomarsino VN, O\u2019Malley TT, et al. An in vitro paradigm to assess potential anti-A\u03b2 antibodies for Alzheimer\u2019s disease. Nat Commun. 2018;9(1):2676.","journal-title":"Nat Commun"},{"key":"558_CR7","doi-asserted-by":"crossref","unstructured":"Negri J, Menon V, Young-Pearse TL. Assessment of spontaneous neuronal activity in vitro using multi-well multi-electrode arrays: implications for assay development. eNeuro. 2020;7(1):ENEURO.0080-19.2019.","DOI":"10.1523\/ENEURO.0080-19.2019"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-biochem-013118-111518","volume":"88","author":"B Breiden","year":"2019","unstructured":"Breiden B, Sandhoff K. Lysosomal Glycosphingolipid storage diseases. Annu Rev Biochem. 2019;88:461\u201385.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"558_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 2013;78(5):785\u201398.","journal-title":"Neuron."},{"issue":"13","key":"558_CR10","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/hmg\/ddu064","volume":"23","author":"CR Muratore","year":"2014","unstructured":"Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LNP, et al. The familial Alzheimer\u2019s disease APPV717I mutation alters APP processing and tau expression in iPSC-derived neurons. Hum Mol Genet. 2014;23(13):3523\u201336.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"558_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, et al. Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med. 2008;14(8):837\u201342.","journal-title":"Nat Med"},{"issue":"2","key":"558_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","volume":"9","author":"T Yang","year":"2013","unstructured":"Yang T, Hong S, O\u2019Malley T, Sperling RA, Walsh DM, Selkoe DJ. New ELISAs with high specificity for soluble oligomers of amyloid \u03b2-protein detect natural A\u03b2 oligomers in human brain but not CSF. Alzheimers Dement. 2013;9(2):99\u2013112.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"558_CR13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/alz.12457","volume":"18","author":"L Liu","year":"2022","unstructured":"Liu L, Kwak H, Lawton TL, Jin S-X, Meunier AL, Dang Y, et al. An ultra-sensitive immunoassay detects and quantifies soluble A\u03b2 oligomers in human plasma. Alzheimers Dement. 2022;18(6):1186\u2013202.","journal-title":"Alzheimers Dement"},{"key":"558_CR14","doi-asserted-by":"crossref","unstructured":"Liu L, Lauro BM, He A, Lee H, Bhattarai S, Wolfe MS, et al. Identification of the A\u03b237\/42 peptide ratio in CSF as an improved A\u03b2 biomarker for Alzheimer\u2019s disease. Alzheimers Dement. 2022.","DOI":"10.1002\/alz.12646"},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2022.04.077","volume":"611","author":"L Liu","year":"2022","unstructured":"Liu L, Cai Y, Lauro BM, Meunier AL, Chhatwal J, Selkoe DJ. Generation and application of semi-synthetic p-Tau181 calibrator for immunoassay calibration. Biochem Biophys Res Commun. 2022;611:85\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"558_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4(1):60\u201372.e4.","journal-title":"Cell Syst"},{"issue":"20","key":"558_CR17","doi-asserted-by":"publisher","first-page":"1800108","DOI":"10.1002\/pmic.201800108","volume":"18","author":"MH Abreha","year":"2018","unstructured":"Abreha MH, Dammer EB, Ping L, Zhang T, Duong DM, Gearing M, et al. Quantitative analysis of the brain Ubiquitylome in Alzheimer\u2019s disease. Proteomics. 2018;18(20):1800108.","journal-title":"Proteomics."},{"issue":"9","key":"558_CR18","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13(9):2513\u201326.","journal-title":"Mol Cell Proteomics"},{"key":"558_CR19","volume-title":"Bioinformatics","author":"W Huber","year":"2002","unstructured":"Huber W, Von Heydebreck A, S\u00fcltmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. In: Bioinformatics; 2002."},{"key":"558_CR20","unstructured":"V\u00e4likangas T, Suomi T, Elo LL. A systematic evaluation of normalization methods in quantitative label-free proteomics. Brief Bioinform. 2018;19(1):1-11."},{"issue":"Suppl","key":"558_CR21","first-page":"16","volume":"13","author":"YV Karpievitch","year":"2012","unstructured":"Karpievitch YV, Dabney AR, Smith RD. Normalization and missing value imputation for label-free LC-MS analysis. BMC Bioinformatics. 2012;13(Suppl):16.","journal-title":"BMC Bioinformatics"},{"key":"558_CR22","volume-title":"Package \u201cnlme\u201d: linear and nonlinear mixed effects models. Version","author":"J Pinheiro","year":"2018","unstructured":"Pinheiro J, Bates D, DebRoy S, Sarkar D, Authors E, Heisterkamp S, et al. Package \u201cnlme\u201d: linear and nonlinear mixed effects models. Version. 2018."},{"key":"558_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0318-1","volume-title":"Mixed-effects models in S and S-Plus: statistics and computing. Mixed-Effects Models in S and S-PLUS","author":"JC Pinheiro","year":"2000","unstructured":"Pinheiro JC, Bates DM. Mixed-effects models in S and S-Plus: statistics and computing. Mixed-Effects Models in S and S-PLUS; 2000."},{"key":"558_CR24","volume-title":"ggplot2 elegant graphics for data analysis (use R!)","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2 elegant graphics for data analysis (use R!): Springer; 2016."},{"key":"558_CR25","volume-title":"Ggpubr: \u201cggplot2\u201d based publication ready plots. R package version 0.2","author":"A Kassambara","year":"2018","unstructured":"Kassambara A. Ggpubr: \u201cggplot2\u201d based publication ready plots. R package version 0.2. 2018. https:\/\/CRAN.R-project.org\/package=ggpubr. https:\/\/CRANR-project.org\/package=ggpubr."},{"key":"558_CR26","volume-title":"Create Awesome HTML Table with knitr::kable and kableExtra. Create awesome HTML table with knitr::kable and kableExtra","author":"H Zhu","year":"2018","unstructured":"Zhu H. Create Awesome HTML Table with knitr::kable and kableExtra. Create awesome HTML table with knitr::kable and kableExtra; 2018."},{"key":"558_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/00401706.1990.10484648","volume":"32","author":"WS Sarle","year":"1990","unstructured":"Sarle WS, Jain AK, Dubes RC. Algorithms for clustering data. Technometrics. 1990;32:2.","journal-title":"Technometrics."},{"key":"558_CR28","doi-asserted-by":"crossref","unstructured":"Oberg AL, Mahoney DW, Eckel-Passow JE, Malone CJ, Wolfinger RD, Hill EG, et al. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J Proteome Res. 2008;7(1):225-33.","DOI":"10.1021\/pr700734f"},{"key":"558_CR29","doi-asserted-by":"crossref","unstructured":"Ping L, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI, et al. Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s disease. Sci Data. 2018;5:180036.","DOI":"10.1038\/sdata.2018.36"},{"key":"558_CR30","doi-asserted-by":"crossref","unstructured":"Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer\u2019s disease. Sci Adv. 2020;6(43):eaaz9360.","DOI":"10.1126\/sciadv.aaz9360"},{"issue":"2","key":"558_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-021-00999-y","volume":"25","author":"ECB Johnson","year":"2022","unstructured":"Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, et al. Large-scale deep multi-layer analysis of Alzheimer\u2019s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci. 2022;25(2):213\u201325.","journal-title":"Nat Neurosci"},{"key":"558_CR32","doi-asserted-by":"crossref","unstructured":"Beckmann ND, Lin WJ, Wang M, Cohain AT, Charney AW, Wang P, et al. Multiscale causal networks identify VGF as a key regulator of Alzheimer\u2019s disease. Nat Commun. 2020;11(1):3942.","DOI":"10.1038\/s41467-020-17405-z"},{"issue":"1","key":"558_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-020-00377-5","volume":"15","author":"S Rayaprolu","year":"2020","unstructured":"Rayaprolu S, Gao T, Xiao H, Ramesha S, Weinstock LD, Shah J, et al. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):28.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"558_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","volume":"35","author":"W Kamphuis","year":"2014","unstructured":"Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi E-J, Moeton M, et al. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(3):492\u2013510.","journal-title":"Neurobiol Aging"},{"issue":"6880","key":"558_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416(6880):535\u20139.","journal-title":"Nature."},{"issue":"6","key":"558_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 2009;62(6):788\u2013801.","journal-title":"Neuron."},{"issue":"11","key":"558_CR37","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","volume":"27","author":"GM Shankar","year":"2007","unstructured":"Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci. 2007;27(11):2866\u201375.","journal-title":"J Neurosci"},{"issue":"1","key":"558_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67(1):122\u201331.","journal-title":"Ann Neurol"},{"issue":"12","key":"558_CR39","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","volume":"283","author":"J N\u00e4slund","year":"2000","unstructured":"N\u00e4slund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA. 2000;283(12):1571\u20137.","journal-title":"JAMA."},{"issue":"Pt 2","key":"558_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1113\/jphysiol.2005.103754","volume":"572","author":"M Townsend","year":"2006","unstructured":"Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol. 2006;572(Pt 2):477\u201392.","journal-title":"J Physiol"},{"issue":"8","key":"558_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, et al. Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 2018;14(8):989\u201397.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"558_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","volume":"12","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy NR, Bateman RJ, Hirtz C, Marin P, Becher F, Sato C, et al. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification. Alzheimers Res Ther. 2020;12(1):26.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"558_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci. 2018;21(6):811\u20139.","journal-title":"Nat Neurosci"},{"key":"558_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fgene.2018.00294","volume":"9","author":"S Tasaki","year":"2018","unstructured":"Tasaki S, Gaiteri C, Mostafavi S, Yu L, Wang Y, De Jager PL, et al. Multi-omic directed networks describe features of gene regulation in aged brains and expand the set of genes driving cognitive decline. Front Genet. 2018;9:294.","journal-title":"Front Genet"},{"issue":"25","key":"558_CR45","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1016\/j.febslet.2005.08.081","volume":"579","author":"S Mencarelli","year":"2005","unstructured":"Mencarelli S, Cavalieri C, Magini A, Tancini B, Basso L, Lemansky P, et al. Identification of plasma membrane associated mature beta-hexosaminidase a, active towards GM2 ganglioside, in human fibroblasts. FEBS Lett. 2005;579(25):5501\u20136.","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"558_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-011-1163-0","volume":"363","author":"B Tancini","year":"2012","unstructured":"Tancini B, Magini A, Bortot B, Polchi A, Urbanelli L, Sonnino S, et al. \u0392-hexosaminidase over-expression affects lysosomal glycohydrolases expression and glycosphingolipid metabolism in mammalian cells. Mol Cell Biochem. 2012;363(1\u20132):109\u201318.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"558_CR47","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1073\/pnas.76.2.982","volume":"76","author":"JW Kusiak","year":"1979","unstructured":"Kusiak JW, Toney JH, Quirk JM, Brady RO. Specific binding of 125I-labeled beta-hexosaminidase a to rat brain synaptosomes. Proc Natl Acad Sci U S A. 1979;76(2):982\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"558_CR48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, et al. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med. 2020;26(5):769\u201380.","journal-title":"Nat Med"},{"issue":"3","key":"558_CR49","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1006\/jmbi.2000.4225","volume":"304","author":"CS Wright","year":"2000","unstructured":"Wright CS, Li SC, Rastinejad F. Crystal structure of human GM2-activator protein with a novel beta-cup topology. J Mol Biol. 2000;304(3):411\u201322.","journal-title":"J Mol Biol"},{"issue":"21","key":"558_CR50","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.neuron.2021.08.003","volume":"109","author":"VN Lagomarsino","year":"2021","unstructured":"Lagomarsino VN, Pearse RV, Liu L, Hsieh Y-C, Fernandez MA, Vinton EA, et al. Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron. 2021;109(21):3402\u20133420.e9.","journal-title":"Neuron."},{"key":"558_CR51","doi-asserted-by":"crossref","unstructured":"Silva MC, Haggarty SJ. Tauopathies: deciphering disease mechanisms to develop effective therapies. Int J Mol Sci. 2020;21(23):8948.","DOI":"10.3390\/ijms21238948"},{"issue":"12","key":"558_CR52","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/membranes10120406","volume":"10","author":"B Tancini","year":"2020","unstructured":"Tancini B, Buratta S, Delo F, Sagini K, Chiaradia E, Pellegrino RM, et al. Lysosomal exocytosis: the extracellular role of an intracellular organelle. Membranes (Basel). 2020;10(12):406.","journal-title":"Membranes (Basel)"},{"issue":"6","key":"558_CR53","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.bpj.2017.03.009","volume":"113","author":"M Cebecauer","year":"2017","unstructured":"Cebecauer M, Hof M, Amaro M. Impact of GM1 on membrane-mediated aggregation\/Oligomerization of \u03b2-amyloid: unifying view. Biophys J. 2017;113(6):1194\u20139.","journal-title":"Biophys J"},{"key":"558_CR54","doi-asserted-by":"crossref","first-page":"193618","DOI":"10.4061\/2011\/193618","volume":"2011","author":"T Ariga","year":"2011","unstructured":"Ariga T, Wakade C, Yu RK. The pathological roles of ganglioside metabolism in Alzheimer\u2019s disease: effects of gangliosides on neurogenesis. Int J Alzheimers Dis. 2011;2011:193618.","journal-title":"Int J Alzheimers Dis"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00558-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T07:28:51Z","timestamp":1728026931000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00558-4","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Brain tissue was obtained postmortem following IRB review and approval through The Rush Alzheimer\u2019s Disease Center repository with relevant material and data transfer agreements, and Mass General Brigham.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the contents of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}